Development of a proto-type vaccine against gastrointestinal nematode larvae. Gastrointestinal parasites are the major cause of production losses in the Australian sheep and wool industries. Drug treatment is predominantly used to control infections but drug resistance has reached critical levels and is threatening the viability of sheep production in many rural areas. In collaboration with an international Animal Health company, we aim to develop vaccines against these parasites and provide a c ....Development of a proto-type vaccine against gastrointestinal nematode larvae. Gastrointestinal parasites are the major cause of production losses in the Australian sheep and wool industries. Drug treatment is predominantly used to control infections but drug resistance has reached critical levels and is threatening the viability of sheep production in many rural areas. In collaboration with an international Animal Health company, we aim to develop vaccines against these parasites and provide a clean, non-toxic alternative to drug treatment. The groundbreaking research involved in this project will also keep Australian animal scientists at the forefront of vaccine research and increase their capacity to attract further support from Industry.Read moreRead less
Investigation of the immunological properties of a novel adjuvant in sheep. The induction of strong immune responses without side effects is a highly desirable goal in vaccine R&D. The recently developed adjuvant DCtag utilises unique properties of dendritic cells to boost both cellular and humoral immune responses without tissue damage. This project will identify the mechanisms of immune induction of DCtag using unique properties of our sheep cannulation model. This will allow further optimisat ....Investigation of the immunological properties of a novel adjuvant in sheep. The induction of strong immune responses without side effects is a highly desirable goal in vaccine R&D. The recently developed adjuvant DCtag utilises unique properties of dendritic cells to boost both cellular and humoral immune responses without tissue damage. This project will identify the mechanisms of immune induction of DCtag using unique properties of our sheep cannulation model. This will allow further optimisation of DCtag adjuvanticity in sheep, which will then be applied to the delivery of a prototype peptide based vaccine against foot and mouth disease virus, a veterinary disease of global importance, hereby increasing Australia's leadership in biotechnology.Read moreRead less
Application of DNA vaccination to the control of gastrointestinal nematodes in livestock. Gastrointestinal nematode parasites inflict great losses in sheep and cattle and reliance on anthelmintic drugs for their control is problematic. Vaccination would provide a better alternative but has been difficult to achieve. This proposal aims to apply novel DNA vaccination strategies to the development of parasite vaccines through optimisation of DNA delivery, development of new vaccination vectors and ....Application of DNA vaccination to the control of gastrointestinal nematodes in livestock. Gastrointestinal nematode parasites inflict great losses in sheep and cattle and reliance on anthelmintic drugs for their control is problematic. Vaccination would provide a better alternative but has been difficult to achieve. This proposal aims to apply novel DNA vaccination strategies to the development of parasite vaccines through optimisation of DNA delivery, development of new vaccination vectors and modulation of immune responses by co-delivery of cytokine genes. The results of these studies will not only add a new approach to vaccine development against gastrointestinal parasites but will also contribute to our knowledge of DNA vaccination in large animals.Read moreRead less
Application of in vivo electroporation to DNA immunisation. The in vivo delivery of plasmid DNA induces immune responses to the encoded protein vaccine. In large animals including humans, DNA vaccination needs to be further improved before becoming a commercial reality, at least partially due to the very low levels of expression in vivo. In vivo electroporation has proven to be an effective way to enhance the level of protein expression and increase DNA vaccine efficacy. We combine enhanced in ....Application of in vivo electroporation to DNA immunisation. The in vivo delivery of plasmid DNA induces immune responses to the encoded protein vaccine. In large animals including humans, DNA vaccination needs to be further improved before becoming a commercial reality, at least partially due to the very low levels of expression in vivo. In vivo electroporation has proven to be an effective way to enhance the level of protein expression and increase DNA vaccine efficacy. We combine enhanced in vivo expression using electroporation with the co-delivery of plasmids encoding cytokines to enhance and modulate DNA vaccine in sheep. We will apply our findings to bovine viral diarrhoea virus (BVDV), both as an animal model for humans and as an economically important diseases of livestock.Read moreRead less